BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, Bell SC, Thomson RM, Miles JJ. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol 2020;11:303. [DOI: 10.3389/fimmu.2020.00303] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Dohál M, Porvazník I, Solovič I, Mokrý J. Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections. Microorganisms 2021;9:2237. [PMID: 34835363 DOI: 10.3390/microorganisms9112237] [Reference Citation Analysis]
2 Beuchel A, Robaa D, Negatu DA, Madani A, Alvarez N, Zimmerman MD, Richter A, Mann L, Hoenke S, Csuk R, Dick T, Imming P. Structure-Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors. ACS Med Chem Lett 2022;13:417-27. [PMID: 35300094 DOI: 10.1021/acsmedchemlett.1c00549] [Reference Citation Analysis]
3 Cheng L, Chen S, Lou H, Gui X, Shen X, Cao J, Sha W, Sun Q. Factors Associated with Treatment Outcome in Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Large Population-Based Retrospective Cohort Study in Shanghai. TropicalMed 2022;7:27. [DOI: 10.3390/tropicalmed7020027] [Reference Citation Analysis]
4 Orujyan D, Narinyan W, Rangarajan S, Rangchaikul P, Prasad C, Saviola B, Venketaraman V. Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections. Vaccines 2022;10:390. [DOI: 10.3390/vaccines10030390] [Reference Citation Analysis]
5 Singh AK, Netea MG, Bishai WR. BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases. J Clin Invest 2021;131:148291. [PMID: 34060492 DOI: 10.1172/JCI148291] [Reference Citation Analysis]
6 Kim YJ, Lee JY, Lee JJ, Jeon SM, Silwal P, Kim IS, Kim HJ, Park CR, Chung C, Han JE, Choi JW, Tak EJ, Yoo JH, Jeong SW, Kim DY, Ketphan W, Kim SY, Jhun BW, Whang J, Kim JM, Eoh H, Bae JW, Jo EK. Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection. Gut Microbes 2022;14:2073132. [PMID: 35579969 DOI: 10.1080/19490976.2022.2073132] [Reference Citation Analysis]
7 van Ingen J, Obradovic M, Hassan M, Lesher B, Hart E, Chatterjee A, Daley CL. Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments. Expert Rev Respir Med 2021;15:1387-401. [PMID: 34612115 DOI: 10.1080/17476348.2021.1987891] [Reference Citation Analysis]
8 Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. Nanomaterials (Basel) 2021;11:2060. [PMID: 34443891 DOI: 10.3390/nano11082060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Phoompoung P, Chayakulkeeree M. Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease. J Fungi (Basel) 2020;6:E346. [PMID: 33302348 DOI: 10.3390/jof6040346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Pidot SJ, Porter JL, Lister T, Stinear TP. In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera. PLoS Negl Trop Dis 2021;15:e0009636. [PMID: 34310615 DOI: 10.1371/journal.pntd.0009636] [Reference Citation Analysis]
11 Akrami S, Dokht Khosravi A, Hashemzadeh M. Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study. Pathog Glob Health 2022;:1-11. [PMID: 35261334 DOI: 10.1080/20477724.2022.2049029] [Reference Citation Analysis]
12 Davis WC, Abdellrazeq GS, Mahmoud AH, Park KT, Elnaggar MM, Donofrio G, Hulubei V, Fry LM. Advances in Understanding of the Immune Response to Mycobacterial Pathogens and Vaccines through Use of Cattle and Mycobacterium avium subsp. paratuberculosis as a Prototypic Mycobacterial Pathogen. Vaccines (Basel) 2021;9:1085. [PMID: 34696193 DOI: 10.3390/vaccines9101085] [Reference Citation Analysis]
13 Saxena S, Spaink HP, Forn-Cuní G. Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models. Biology (Basel) 2021;10:96. [PMID: 33573039 DOI: 10.3390/biology10020096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pereira AC, Ramos B, Reis AC, Cunha MV. Non-Tuberculous Mycobacteria: Molecular and Physiological Bases of Virulence and Adaptation to Ecological Niches. Microorganisms 2020;8:E1380. [PMID: 32916931 DOI: 10.3390/microorganisms8091380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kalaiarasan E, Thangavelu K, Krishnapriya K, Muthuraj M, Jose M, Joseph NM. Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates. Tuberculosis (Edinb) 2020;125:101988. [PMID: 32916384 DOI: 10.1016/j.tube.2020.101988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhang Y, Hill AT. Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection. Expert Rev Respir Med 2021;15:737-44. [PMID: 34039231 DOI: 10.1080/17476348.2021.1875821] [Reference Citation Analysis]
17 Thangavelu K, Krishnakumariamma K, Pallam G, Dharm Prakash D, Chandrashekar L, Kalaiarasan E, Das S, Muthuraj M, Joseph NM. Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. J Infect Public Health 2021;14:320-3. [PMID: 33618276 DOI: 10.1016/j.jiph.2020.12.027] [Reference Citation Analysis]
18 Cronin RM, Ferrell MJ, Cahir CW, Champion MM, Champion PA. Proteo-genetic analysis reveals clear hierarchy of ESX-1 secretion in Mycobacterium marinum. Proc Natl Acad Sci U S A 2022;119:e2123100119. [PMID: 35671426 DOI: 10.1073/pnas.2123100119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Rosenbloom R, Gavrish I, Tseng AE, Seidel K, Yabaji SM, Gertje HP, Huber BR, Kramnik I, Crossland NA. Progression and Dissemination of Pulmonary Mycobacterium Avium Infection in a Susceptible Immunocompetent Mouse Model. IJMS 2022;23:5999. [DOI: 10.3390/ijms23115999] [Reference Citation Analysis]
20 Tanaka H, Asakura T, Suzuki S, Okamori S, Kusumoto T, Ogawa T, Uno S, Morita A, Lee H, Namkoong H, Kamata H, Sato Y, Uwamino Y, Nishimura T, Ishii M, Fukunaga K, Hasegawa N. Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study. BMC Pulm Med 2022;22:202. [PMID: 35596169 DOI: 10.1186/s12890-022-01991-3] [Reference Citation Analysis]
21 Silva CAME, Rojony R, Bermudez LE, Danelishvili L. Short-Chain Fatty Acids Promote Mycobacterium avium subsp. hominissuis Growth in Nutrient-Limited Environments and Influence Susceptibility to Antibiotics. Pathogens 2020;9:E700. [PMID: 32859077 DOI: 10.3390/pathogens9090700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Nakajima M, Matsuyama M, Kawaguchi M, Matsumura S, Kiwamoto T, Matsuno Y, Morishima Y, Yoshida K, Sherpa MT, Yazaki K, Tanaka R, Okiyama N, Muratani M, Ishii Y, Hizawa N. Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium. Sci Rep 2021;11:18008. [PMID: 34504192 DOI: 10.1038/s41598-021-97391-4] [Reference Citation Analysis]
23 Ferrell KC, Johansen MD, Triccas JA, Counoupas C. Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design. Front Microbiol 2022;13:842017. [DOI: 10.3389/fmicb.2022.842017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Johansen MD, Kremer L. CFTR Depletion Confers Hypersusceptibility to Mycobacterium fortuitum in a Zebrafish Model. Front Cell Infect Microbiol 2020;10:357. [PMID: 32850470 DOI: 10.3389/fcimb.2020.00357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Chirakos AE, Balaram A, Conrad W, Champion PA. Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum. Microbiol Mol Biol Rev 2020;84. [DOI: 10.1128/mmbr.00082-19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kilinç G, Walburg KV, Franken KLMC, Valkenburg ML, Aubry A, Haks MC, Saris A, Ottenhoff THM. Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium. Front Cell Infect Microbiol 2022;12:872361. [DOI: 10.3389/fcimb.2022.872361] [Reference Citation Analysis]
27 Joao I, Bujdáková H, Jordao L. Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients. Antibiotics (Basel) 2020;9:E771. [PMID: 33147819 DOI: 10.3390/antibiotics9110771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhou W, Zhao H, Yuan H, Zhang G, Liu Q, Yang J. Prevalence and Antimicrobial Susceptibility of Non-tuberculous Mycobacteria Isolated from Sputum Samples of Patients with Pulmonary Infections in China. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.109676] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Muñoz-Muñoz L, Shoen C, Sweet G, Vitoria A, Bull TJ, Cynamon M, Thompson CJ, Ramón-García S. Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria. Antibiotics (Basel) 2021;10:381. [PMID: 33916775 DOI: 10.3390/antibiotics10040381] [Reference Citation Analysis]
30 Schildhaus HU, Steindor M, Kölsch B, Herold T, Buer J, Kehrmann J. GenoType CM Direct® and VisionArray Myco® for the Rapid Identification of Mycobacteria from Clinical Specimens. J Clin Med 2022;11:2404. [PMID: 35566531 DOI: 10.3390/jcm11092404] [Reference Citation Analysis]
31 Gorzynski M, Week T, Jaramillo T, Dzalamidze E, Danelishvili L. Mycobacterium abscessus Genetic Determinants Associated with the Intrinsic Resistance to Antibiotics. Microorganisms 2021;9:2527. [PMID: 34946129 DOI: 10.3390/microorganisms9122527] [Reference Citation Analysis]
32 Kang M, Kim HW, Yu AR, Yang JS, Lee SH, Lee JW, Yoon HS, Lee BS, Park HW, Lee SK, Lee S, Whang J, Kim JS. Comparison of Macrophage Immune Responses and Metabolic Reprogramming in Smooth and Rough Variant Infections of Mycobacterium mucogenicum. Int J Mol Sci 2022;23:2488. [PMID: 35269631 DOI: 10.3390/ijms23052488] [Reference Citation Analysis]
33 Mok S, Flanagan PR, Roycroft E, Rogers TR, Fitzgibbon MM. Draft Genome Sequences of Clinical Respiratory Isolates of Mycobacterium goodii Recovered in Ireland. Microbiol Resour Announc 2021;10:e0053121. [PMID: 34351236 DOI: 10.1128/MRA.00531-21] [Reference Citation Analysis]
34 Frutos R, Javelle E, Barberot C, Gavotte L, Tissot-Dupont H, Devaux CA. Origin of COVID-19: Dismissing the Mojiang mine theory and the laboratory accident narrative. Environ Res 2021;:112141. [PMID: 34597664 DOI: 10.1016/j.envres.2021.112141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Abe Y, Fukushima K, Hosono Y, Matsumoto Y, Motooka D, Ose N, Nakamura S, Kitada S, Kida H, Kumanogoh A. Host Immune Response and Novel Diagnostic Approach to NTM Infections. Int J Mol Sci 2020;21:E4351. [PMID: 32570978 DOI: 10.3390/ijms21124351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Eskandari SK, Jonkers SY, Almesned MAM, Akkerman OW, Verschuuren EAM, Gan CT. Recurrent fever 3 years post-lung transplantation: A treacherous case of Mycobacterium genavense. Transpl Infect Dis 2021;:e13741. [PMID: 34607392 DOI: 10.1111/tid.13741] [Reference Citation Analysis]
37 Nishii Y, Furuhashi K, Nakamura S, Nishio M, Nakamura Y, Ushiro K, Ito K, Sakaguchi T, Suzuki Y, Fujiwara K, Yasuma T, Kobayashi T, D'Alessandro-Gabazza C, Gabazza EC, Taguchi O, Hataji O. The Potential of Digital Polymerase Chain Reaction for Improving Diagnostic Yield of Nontuberculous Mycobacteria Pulmonary Disease. Infect Drug Resist 2021;14:5079-87. [PMID: 34880633 DOI: 10.2147/IDR.S338165] [Reference Citation Analysis]
38 Strong EJ, Lee S. Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria. Front Microbiol 2020;11:614313. [PMID: 33519771 DOI: 10.3389/fmicb.2020.614313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Larsen SE, Reese VA, Pecor T, Berube BJ, Cooper SK, Brewer G, Ordway D, Henao-Tamayo M, Podell BK, Baldwin SL, Coler RN. Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models. Sci Rep 2021;11:9040. [PMID: 33907221 DOI: 10.1038/s41598-021-88291-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Blanc SM, Pender D, Vinnard C, Gennaro ML, Fahrenfeld NL. Nontuberculous Mycobacteria in the Biofilm Microbiome of Private Well and Premise Plumbing. Environmental Engineering Science 2021;38:607-25. [DOI: 10.1089/ees.2020.0528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Twabi HH, Mukoka-Thindwa M, Shani D, Nliwasa M, Corbett EL. Non-Tuberculous Mycobacterial Pulmonary Disease identified during community-based screening for Mycobacterium Tuberculosis: a case report. Malawi Med J 2021;33:65-7. [PMID: 34422236 DOI: 10.4314/mmj.v33i1.10] [Reference Citation Analysis]
42 Mussi VO, Simão TLBV, Almeida FM, Machado E, de Carvalho LD, Calixto SD, Sales GAM, Carvalho ECQ, Vasconcellos SEG, Catanho M, Suffys PN, Lasunskaia EB. A Murine Model of Mycobacterium kansasii Infection Reproducing Necrotic Lung Pathology Reveals Considerable Heterogeneity in Virulence of Clinical Isolates. Front Microbiol 2021;12:718477. [PMID: 34504483 DOI: 10.3389/fmicb.2021.718477] [Reference Citation Analysis]
43 Zulu M, Monde N, Nkhoma P, Malama S, Munyeme M. Nontuberculous Mycobacteria in Humans, Animals, and Water in Zambia: A Systematic Review. Front Trop Dis 2021;2:679501. [DOI: 10.3389/fitd.2021.679501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Rubinstein M, Grossman R, Nissan I, Schwaber MJ, Carmeli Y, Kaidar-Shwartz H, Dveyrin Z, Rorman E. Mycobacterium intracellulare subsp. chimaera from Cardio Surgery Heating-Cooling Units and from Clinical Samples in Israel Are Genetically Unrelated. Pathogens 2021;10:1392. [PMID: 34832548 DOI: 10.3390/pathogens10111392] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SHE, Netea MG, Mandalakas AM. 100 years of Mycobacterium bovis bacille Calmette-Guérin. Lancet Infect Dis 2021:S1473-3099(21)00403-5. [PMID: 34506734 DOI: 10.1016/S1473-3099(21)00403-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Blanc S, Robinson D, Fahrenfeld N. Potential for nontuberculous mycobacteria proliferation in natural and engineered water systems due to climate change: A literature review. City and Environment Interactions 2021;11:100070. [DOI: 10.1016/j.cacint.2021.100070] [Reference Citation Analysis]
47 Grey ABJ, Cadelis MM, Diao Y, Park D, Lumley T, Weir BS, Copp BR, Wiles S. Screening of Fungi for Antimycobacterial Activity Using a Medium-Throughput Bioluminescence-Based Assay. Front Microbiol 2021;12:739995. [PMID: 34552577 DOI: 10.3389/fmicb.2021.739995] [Reference Citation Analysis]
48 Iakobachvili N, Leon-Icaza SA, Knoops K, Sachs N, Mazères S, Simeone R, Peixoto A, Bernard C, Murris-Espin M, Mazières J, Cam K, Chalut C, Guilhot C, López-Iglesias C, Ravelli RBG, Neyrolles O, Meunier E, Lugo-Villarino G, Clevers H, Cougoule C, Peters PJ. Mycobacteria-host interactions in human bronchiolar airway organoids. Mol Microbiol 2021. [PMID: 34605588 DOI: 10.1111/mmi.14824] [Reference Citation Analysis]
49 Quang NT, Jang J. Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus. Front Pharmacol 2021;12:724725. [PMID: 34526902 DOI: 10.3389/fphar.2021.724725] [Reference Citation Analysis]
50 Gupta KR, Arora G, Mattoo A, Sajid A. Stringent Response in Mycobacteria: From Biology to Therapeutic Potential. Pathogens 2021;10:1417. [PMID: 34832573 DOI: 10.3390/pathogens10111417] [Reference Citation Analysis]
51 Strong E, Hart B, Wang J, Orozco MG, Lee S. Induced Synthesis of Mycolactone Restores the Pathogenesis of Mycobacterium ulcerans In Vitro and In Vivo. Front Immunol 2022;13:750643. [DOI: 10.3389/fimmu.2022.750643] [Reference Citation Analysis]
52 Armstrong DT, Parrish N. Current Updates on Mycobacterial Taxonomy, 2018 to 2019. J Clin Microbiol 2021;59:e0152820. [PMID: 33853836 DOI: 10.1128/JCM.01528-20] [Reference Citation Analysis]
53 Taur PD, Gowri V, Pandrowala AA, Iyengar VV, Chougule A, Golwala Z, Chandak S, Agarwal R, Keni P, Dighe N, Bodhanwala M, Prabhu S, George B, Fouzia NA, Edison ES, Arunachalam AK, Madkaikar MR, Dalvi AD, Yadav RM, Bargir UA, Kambli PM, Rawat A, Das J, Joshi V, Pilania RK, Jindal AK, Bhat S, Bhattad S, Unni J, Radhakrishnan N, Raj R, Uppuluri R, Patel S, Lashkari HP, Aggarwal A, Kalra M, Udwadia Z, Bafna VS, Kanade T, Puel A, Bustamante J, Casanova JL, Desai MM. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India. Front Immunol 2021;12:631298. [PMID: 33732252 DOI: 10.3389/fimmu.2021.631298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Burke A, Smith D, Coulter C, Bell SC, Thomson R, Roberts JA. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis. Clin Pharmacokinet 2021. [PMID: 33982266 DOI: 10.1007/s40262-021-01010-4] [Reference Citation Analysis]
55 Cushman J, Freeman E, McCallister S, Schumann A, Hutchison KW, Molloy SD. Increased whiB7 expression and antibiotic resistance in Mycobacterium chelonae carrying two prophages. BMC Microbiol 2021;21:176. [PMID: 34107872 DOI: 10.1186/s12866-021-02224-z] [Reference Citation Analysis]
56 Ryan RYM, Fernandez A, Wong Y, Miles JJ, Cock IE. The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes. Sci Rep 2021;11:5519. [PMID: 33750911 DOI: 10.1038/s41598-021-85211-8] [Reference Citation Analysis]
57 Hajikhani B, Nasiri MJ, Hosseini SS, Khalili F, Karimi-Yazdi M, Hematian A, Nojookambari NY, Goudarzi M, Dadashi M, Mirsaeidi M. Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study. J Glob Antimicrob Resist 2021;26:188-93. [PMID: 34153525 DOI: 10.1016/j.jgar.2021.06.002] [Reference Citation Analysis]
58 Weathered C, Pennington K, Escalante P, Pienaar E. The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection. J Theor Biol 2021;:110949. [PMID: 34717938 DOI: 10.1016/j.jtbi.2021.110949] [Reference Citation Analysis]
59 Mori S, Koga Y, Nakamura K, Hirooka S, Matsuoka T, Uramoto H, Sakamoto O, Ueki Y. Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study. PLoS One 2020;15:e0243110. [PMID: 33264361 DOI: 10.1371/journal.pone.0243110] [Reference Citation Analysis]
60 Tarashi S, Siadat SD, Fateh A, Tsai F. Nontuberculous Mycobacterial Resistance to Antibiotics and Disinfectants: Challenges Still Ahead. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/8168750] [Reference Citation Analysis]